Approaches to the choice of a statin to treat patients on an outpatient basis
- Authors: Ostroumova O.D1,2, Dudaev V.A1, Schukina G.N1
-
Affiliations:
- A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
- I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation
- Issue: Vol 17, No 1 (2015)
- Pages: 44-49
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94228
- ID: 94228
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
O. D Ostroumova
A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation; I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation
Email: ostroumova.olga@mail.ru
д-р мед. наук, проф. каф. факультетской терапии и профболезней ГБОУ ВПО МГМСУ им. А.И.Евдокимова, проф. каф. клинической фармакологии и профболезней ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
V. A Dudaev
A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federationд-р мед. наук, проф. каф. факультетской терапии и профболезней ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
G. N Schukina
A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federationканд. мед. наук, доц. каф. факультетской терапии и профболезней ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
References
- Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации. V пересмотр. Атеросклероз и дислипидемии. 2012; 4 (9): 2-52.
- Клиническая фармакология. Под ред. В.Г.Кукеса. М.: ГЭОТАР-Медиа, 2008; с. 648-65.
- Sever P.S, Dahlof B, Poulter N.R et al. For the ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower - than - average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003; 361: 1149-58.
- La Rosa J, Grundy S.M, Waters D.D et al. For the Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352 (14): 1425-34.
- Cannon C.P, Braunwald E, Mc Cabe C.H et al. For the Pravastatin or Atorvastatin Evaluation and Infection Therapy - Thrombolysis in Myocardial Infarction 22 Investigators. Comparison of Intensive and Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. N Eng J Med 2004; 350: 1495-504.
- Colhoun H.M, Betteridge D.J, Durrington P.N et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomised placebo - controlled trial. Lancet 2004; 364: 685-96.
- Amarenco P, Bogousslavsky J, Callahan A 3rd et al. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High - dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549-59.
- Мухин В.П., Жиляева Ю.А. Дженерические статины в клинической практике: дешевые заменители или достойная альтернатива брендам. Аторвастатин. Архивъ внутр. медицины. 2012; 2 (4): 72-6.
- Ridker P.M, Darielson E, Fonseca F.A et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359 (21): 2195-207.
- Jones P.H, Davidson M.H, Stein E.A et al and STELLAR Study Group. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial). Am J Cardiol 2003; 92: 152-60.